Last €35.55 EUR
Change Today -0.70 / -1.94%
Volume 757.0K
GRF On Other Exchanges
Symbol
Exchange
OTC US
OTC US
NASDAQ GS
OTC US
Continuous
Continuous
Frankfurt
Frankfurt
Mexico
As of 10:51 AM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Anna Veiga Lluch

Independent Director and Member of Appointments & Remuneration Committee, Grifols, S.A.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Ms. Anna Veiga Lluch served as Scientific Director of the Reproductive Medicine Service at Institut Universitari Dexeus from 1982 to 2004 as well as Scientific Coordinator of the European Human Embryonic Stem Cell Registry from 2002 to 2010. Ms. Lluch has been an Independent Director of Grifols, S.A since December 9, 2008. She graduated in Biology (1974-1979) and received her Ph.D. at Universidad Autonoma de Barcelona in 1991. Ms. Lluch received certification as a “Senior ...

Read Full Background

Corporate Headquarters*

Avinguda de la Generalitat, 152-158
Barcelona, Catalonia 08174

Spain

Phone: 34 935 71 22 00
Fax: 34 935 71 02 67

Board Members Memberships*

2008-Present
Independent Director and Member of Appointments & Remuneration Committee

Education*

PhD 1991
Universitat Autònoma de Barcelona
Bachelor's Degree 1979
Universitat Autònoma de Barcelona

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GRF:SM €35.55 EUR -0.70

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$4.3M
Jean-Christophe Tellier Chief Executive Officer and Director
UCB S.A.
--
Hartmut Retzlaff Chairman of the Executive Board and Chief Executive Officer of the Executive Board
Stada-Arzneimittel AG
€3.2M
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.0M
Said Samih Taleb Darwazah Chairman and Chief Executive Officer
Hikma Pharmaceuticals plc
$2.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GRIFOLS SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.